Stock DNA
Miscellaneous Commercial Services
CAD 38 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.00
-48.16%
3.60
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Sep 2024)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-16.67%
0%
-16.67%
6 Months
-28.57%
0%
-28.57%
1 Year
-74.36%
0%
-74.36%
2 Years
194.12%
0%
194.12%
3 Years
42.86%
0%
42.86%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
ASEP Medical Holdings, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.70%
EBIT Growth (5y)
-207.15%
EBIT to Interest (avg)
-4.92
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
3.60
EV to EBIT
-7.72
EV to EBITDA
-10.51
EV to Capital Employed
3.60
EV to Sales
37.98
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-46.63%
ROE (Latest)
-48.16%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'24 - YoY
Sep'24
Sep'23
Change(%)
Net Sales
0.10
0.00
Operating Profit (PBDIT) excl Other Income
-0.50
-1.30
61.54%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.00
-1.60
37.50%
Operating Profit Margin (Excl OI)
-10,841.90%
0.00%
-1,084.19%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2024 is 0.00% vs 0.00% in Sep 2023
Consolidated Net Profit
YoY Growth in quarter ended Sep 2024 is 37.50% vs -45.45% in Sep 2023
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-6.40
-4.20
-52.38%
Interest
0.00
0.00
Exceptional Items
-1.70
-0.40
-325.00%
Consolidate Net Profit
-9.40
-5.80
-62.07%
Operating Profit Margin (Excl OI)
-365,244.20%
0.00%
-36,524.42%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 0.00% vs 0.00% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -62.07% vs -152.17% in Dec 2022
About ASEP Medical Holdings, Inc. 
ASEP Medical Holdings, Inc.
Miscellaneous Commercial Services
No Details Available.
Company Coordinates 
No Company Details Available






